Ayurvedic management of Thalassemia Major-A review of clinical researches conducted at IPGT & RA, Jamnagar
Thalassemia Major is the most common single gene disorder which represents a major health burden worldwide. The available treatment modalities in conventional medicine i.e. blood transfusion (BT) and iron chelation therapies are associated with complications while bone marrow transplantation etc. are out of reach of many. Present study is aimed to highlight the effective role of Ayurvedic medicines i.e. Dhatri Avaleha, Triphaladi Avaleha and Musta-Triphaladi Avaleha in the management of Thalassemia Major. Till date total five clinical researches have been carried out on Thalassemia Major at PG level in the department of Kaumarbhritya at IPGT&RA, Jamnagar. In which a simple random sampling method was followed. Patients were divided into two groups, Group A (Trial group with Ayurvedic drug intervention and BT) and Group B (Control Group with BT and iron chelation therapy). Assessment was done based on the subjective and objective parameters after completion of treatment. The data obtained in clinical studies was analyzed by using suitable statistical tests. The trial drugs were found to be effective on subjective, objective criteria, BT interval and general health status of Thalassemic patients as well as clinically safe.
The author hereby transfers, assigns, or conveys all copyright ownership to the International Journal of Ayurvedic Medicine (IJAM). By this transfer, the article becomes the property of the IJAM and may not be published elsewhere without written permission from the IJAM.
This transfer of copyright also implies transfer of rights for printed, electronic, microfilm, and facsimile publication. No royalty or other monetary compensation will be received for transferring the copyright of the article to the IJAM.
The IJAM, in turn, grants each author the right to republish the article in any book for which he or she is the author or editor, without paying royalties to the IJAM, subject to the express conditions that (a) the author notify IJAM in advance in writing of this republication and (b) a credit line attributes the original publication to IJAM.